Antal Rohit Desai - 17 Sep 2021 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
Director, 10%+ Owner
Signature
/s/ Alaleh Nouri, Attorney-in-Fact for Antal Rohit Desai
Issuer symbol
PRCT
Transactions as of
17 Sep 2021
Net transactions value
+$11,000,000
Form type
4
Filing time
21 Sep 2021, 18:36:22 UTC
Previous filing
16 Sep 2021
Next filing
21 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Conversion of derivative security +49,517 49,517 17 Sep 2021 By The 2:22 DNA Trust F1
transaction PRCT Common Stock Conversion of derivative security +10,084,910 +1445% 10,782,662 17 Sep 2021 By White Tailed Ptarmigan, LP F1, F2
transaction PRCT Common Stock Purchase $11,000,000 +440,000 +4.1% $25.00 11,222,662 17 Sep 2021 By White Tailed Ptarmigan, LP F2, F3
transaction PRCT Common Stock Conversion of derivative security +52,640 52,640 17 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Series C Convertible Preferred Stock Conversion of derivative security -35,220 -100% 0 17 Sep 2021 Common Stock 35,220 Direct F1
transaction PRCT Series E Convertible Preferred Stock Conversion of derivative security -7,284 -100% 0 17 Sep 2021 Common Stock 7,284 Direct F1
transaction PRCT Series F Convertible Preferred Stock Conversion of derivative security -7,468 -100% 0 17 Sep 2021 Common Stock 7,468 Direct F1
transaction PRCT Series G Convertible Preferred Stock Conversion of derivative security -2,668 -100% 0 17 Sep 2021 Common Stock 2,668 Direct F1
transaction PRCT Series D Convertible Preferred Stock Conversion of derivative security -39,164 -100% 0 17 Sep 2021 Common Stock 39,164 By The 2:22 DNA Trust F1
transaction PRCT Series E Convertible Preferred Stock Conversion of derivative security -9,104 -100% 0 17 Sep 2021 Common Stock 9,104 By The 2:22 DNA Trust F1
transaction PRCT Series G Convertible Preferred Stock Conversion of derivative security -1,249 -100% 0 17 Sep 2021 Common Stock 1,249 By The 2:22 DNA Trust F1
transaction PRCT Series D Convertible Preferred Stock Conversion of derivative security -4,712,969 -100% 0 17 Sep 2021 Common Stock 4,712,969 By White Tailed Ptarmigan, LP F1, F2
transaction PRCT Series E Convertible Preferred Stock Conversion of derivative security -3,038,934 -100% 0 17 Sep 2021 Common Stock 3,038,934 By White Tailed Ptarmigan, LP F1, F2
transaction PRCT Series F Convertible Preferred Stock Conversion of derivative security -2,060,802 -100% 0 17 Sep 2021 Common Stock 2,060,802 By White Tailed Ptarmigan, LP F1, F2
transaction PRCT Series G Convertible Preferred Stock Conversion of derivative security -272,205 -100% 0 17 Sep 2021 Common Stock 272,205 By White Tailed Ptarmigan, LP F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date.
F2 Antal Desai, a member of our board of directors and a Partner of CPMG, Inc., along with Kent McGaughy, Jr., the sole shareholder and managing director of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by White Tailed Ptarmigan, LP. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by White Tailed Ptarmigan, LP except to the extent of any pecuniary interest therein.
F3 Represents a purchase in the Issuer's public offering.